Literature DB >> 32365274

The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report.

Maxim Kuzin1, Isabel Scharrer1, Daniele Nolan1, Markus Baumgartner1, Michael Paulzen2,3,4, Georgios Schoretsanitis5, Franziskos Xepapadakos1.   

Abstract

Entities:  

Keywords:  CYP2D6 poor metabolizer; duloxetine; genetic polymorphisms; therapeutic drug monitoring; venlafaxine

Mesh：

Substances：

Year:  2020        PMID： 32365274     DOI： 10.1111/bcpt.13428

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN： 1742-7835            Impact factor:   4.080


× No keyword cloud information.
  1 in total

1.  Role of JNK in the Regulation of Xenobiotic Metabolizing Function of Hepatocytes.

Authors:  O S Bryushinina; Yu G Zyuz'kova; E A Yanovskaya; N Y Abdrashitova; G A Frelikh; A P Lakeev; D V Tsuran; V V Udut; G N Zyuz'kov
Journal:  Bull Exp Biol Med       Date:  2021-12-02       Impact factor: 0.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.